| Rogers Communications Reports First Quarter 2026 Results |
Globe Newswire |
04/22 |
07:00 |
| Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting |
Globe Newswire |
04/22 |
07:00 |
| Green Thumb Industries to Report First Quarter 2026 Financial Results on May 6, 2026 |
Globe Newswire |
04/22 |
07:00 |
| Fidelity D & D Bancorp, Inc. Reports First Quarter 2026 Financial Results |
Globe Newswire |
04/22 |
07:00 |
| NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program |
Globe Newswire |
04/22 |
07:00 |
| Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat |
Globe Newswire |
04/22 |
07:00 |
| Aurora Mobile's EngageLab Redefines AI-Native Customer Engagement at NexTech Week Tokyo Spring 2026 |
Globe Newswire |
04/22 |
07:00 |
| Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast |
Globe Newswire |
04/22 |
07:00 |
| Keel Infrastructure Announces Closing of Paso Pe Sale |
Globe Newswire |
04/22 |
07:00 |
| Coherent Corp. Announces Timing of FY2026 Third Quarter Earnings Release |
Globe Newswire |
04/22 |
07:00 |
| Allpoints Services Names Longtime Homebuilding Executive John Ballard as CRO |
Globe Newswire |
04/22 |
07:00 |
| U.S. Retail Spending Rises in Early Spring, but Underlying Consumer Pressures Signal Caution Ahead, Reports Circana |
Globe Newswire |
04/22 |
07:00 |
| Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer |
Globe Newswire |
04/22 |
07:00 |
| NeurAxis Expands Payer Coverage with Four New Medical Policies |
Globe Newswire |
04/22 |
07:00 |
| Picard Medical / SynCardia Reports Revenue Growth Based on Top-line Results for the First Quarter 2026 |
Globe Newswire |
04/22 |
07:00 |
| Cicero by CGS Immersive Wins Three 2026 TITAN Innovation Awards |
Globe Newswire |
04/22 |
07:00 |
| SEED Therapeutics Reports Tumor Eradication in a Neuroblastoma In Vivo Model with Clinical-Stage RBM39 Molecular Glue Degrader ST-01156 |
Globe Newswire |
04/22 |
07:00 |
| Advantage Solutions Announces Date for its First Quarter 2026 Financial Results and Conference Call |
Globe Newswire |
04/22 |
07:00 |
| Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer |
Globe Newswire |
04/22 |
07:00 |
| Old National Bancorp Reports First Quarter 2026 Results |
Globe Newswire |
04/22 |
07:00 |
| Lantronix to Report Fiscal 2026 Third Quarter Results on May 6, 2026 |
Globe Newswire |
04/22 |
07:00 |
| Ligand to Report First Quarter 2026 Financial Results on May 7, 2026 |
Globe Newswire |
04/22 |
07:00 |
| Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 |
Globe Newswire |
04/22 |
07:00 |
| Following Stryker Cyberattack, Avatier Launches Identity Challenge Card to Protect Organizations When Standard Security Fails |
Globe Newswire |
04/22 |
07:00 |
| NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value |
Globe Newswire |
04/22 |
07:00 |
